What type of release method does Sustol (Granisetron ER) utilize?

Sustol (Granisetron ER) utilizes a subcutaneous release method, which means that it is administered as an injection just beneath the skin. This formulation allows for extended release of the medication, providing prolonged therapeutic effects over a set period. The subcutaneous route is beneficial for drugs like Sustol, as it can ensure a slower absorption rate compared to other routes, leading to sustained levels of the drug in the bloodstream and reducing the frequency of dosages needed.

Understanding the subcutaneous method can be critical in clinical settings, especially in managing symptoms of nausea and vomiting in patients undergoing chemotherapy. It allows healthcare professionals to provide a more convenient and effective long-term treatment option, enhancing patient compliance and improving their quality of care.